Patents Examined by Chu Chuan Liu
  • Patent number: 10376190
    Abstract: The present disclosure relates to noninvasive methods, devices, and systems for measuring various blood constituents or analytes, such as glucose. In an embodiment, a light source comprises LEDs and super-luminescent LEDs. The light source emits light at at least wavelengths of about 1610 nm, about 1640 nm, and about 1665 nm. In an embodiment, the detector comprises a plurality of photodetectors arranged in a special geometry comprising one of a substantially linear substantially equal spaced geometry, a substantially linear substantially non-equal spaced geometry, and a substantially grid geometry.
    Type: Grant
    Filed: May 10, 2019
    Date of Patent: August 13, 2019
    Assignee: Masimo Corporation
    Inventors: Jeroen Poeze, Marcelo Lamego, Sean Merritt, Cristiano Dalvi, Hung Vo, Johannes Bruinsma, Ferdyan Lesmana, Massi Joe E. Kiani, Greg Olsen
  • Patent number: 10362974
    Abstract: Light reflected from a pregnant woman's abdomen and fetus contained therein that has been received by a detector and converted into a reflected electronic signal may be received by a processor. A portion of the reflected electronic signal that is reflected from the fetus may be isolated and the isolated portion of the reflected electronic signal may be analyzed to determine a fetal hemoglobin oxygen saturation level of the fetus. The isolation may be achieved by synchronizing the reflected electronic signal with a fetal heartbeat signal and multiplying the synchronized reflected electronic signal by the synchronized fetal heartbeat signal.
    Type: Grant
    Filed: May 7, 2018
    Date of Patent: July 30, 2019
    Assignee: RAYDIANT OXIMETRY, INC.
    Inventor: Neil Padharia Ray
  • Patent number: 10349898
    Abstract: Automated critical congenital heart defect (“CCHD”) screening systems and processes are described. A caregiver may be guided to use a single or dual sensor pulse oximeter to obtain pre- and post-ductal blood oxygenation measurements. A delta of the measurements indicates the possible existence or nonexistence of a CCHD. Errors in the measurements are reduced by a configurable measurement confidence threshold based on, for example, a perfusion index. Measurement data may be stored and retrieved from a remote data processing center for repeated screenings.
    Type: Grant
    Filed: June 28, 2016
    Date of Patent: July 16, 2019
    Assignee: MASIMO CORPORATION
    Inventors: Ammar Al-Ali, Bilal Muhsin
  • Patent number: 10335068
    Abstract: The present disclosure relates to noninvasive methods, devices, and systems for measuring various blood constituents or analytes, such as glucose. In an embodiment, a light source comprises LEDs and super-luminescent LEDs. The light source emits light at least wavelengths of about 1610 nm, about 1640 nm, and about 1665 nm. In an embodiment, the detector comprises a plurality of photodetectors arranged in a special geometry comprising one of a substantially linear substantially equal spaced geometry, a substantially linear substantially non-equal spaced geometry, and a substantially grid geometry.
    Type: Grant
    Filed: December 28, 2015
    Date of Patent: July 2, 2019
    Assignee: MASIMO CORPORATION
    Inventors: Jeroen Poeze, Marcelo Lamego, Sean Merritt, Cristiano Dalvi, Hung Vo, Johannes Bruinsma, Ferdyan Lesmana, Massi Joe E. Kiani
  • Patent number: 10314540
    Abstract: A vaginal ring sensor device adapted to be placed within the vaginal vault of a user, the device including a ring body, at least one through hole that passes through the ring body, and at least one biosensor structured and arranged to sense and/or measure a parameter of vaginal fluid as such fluid passes through the at least one through hole.
    Type: Grant
    Filed: September 13, 2016
    Date of Patent: June 11, 2019
    Assignee: Johnson & Johnson Consumer Inc.
    Inventors: Richard J. Fougere, Ming Dong
  • Patent number: 10314526
    Abstract: A biosensor including light emitting elements and a light receiving element disposed on a principal surface of a wiring board; a light shielding portion disposed between a light-emitting-element sealing portion and a light-receiving-element sealing portion; a base medium having light transmitting properties, disposed in parallel with the wiring board with the light shielding portion therebetween; an adhesion layer having light transmitting properties that bonds the base medium with the light-emitting-element sealing portion, the light-receiving-element sealing portion, and the light shielding portion; and a first electrocardiograph electrode attached to a principal surface of the base medium. Both end portions of the adhesion layer and both end portions of the base medium are disposed such that they overlap neither of the light-receiving-element sealing portion nor the light-emitting-element sealing portion when viewed from a direction normal to the principal surface of the wiring board.
    Type: Grant
    Filed: February 1, 2017
    Date of Patent: June 11, 2019
    Assignee: MURATA MANUFACTURING CO., LTD.
    Inventors: Toru Shimuta, Yasutaka Fujii
  • Patent number: 10314543
    Abstract: A stand-on physiological sensor (e.g. floormat) measures vital signs and various hemodynamic parameters, including blood pressure and ECG waveforms. The sensor is similar in configuration to a common bathroom scale and includes electrodes that take electrical measurements from a patient's feet to generate bioimpedance waveforms, which are analyzed digitally to extract various other parameters, as well as a cuff-type blood pressure system that takes physical blood pressure measurements at one of the patient's feet. Blood pressure can also be calculated/derived from the bioimpedance waveforms. Measured parameters are transmitted wirelessly to facilitate remote monitoring of the patient for heart failure, chronic heart failure, end-stage renal disease, cardiac arrhythmias, and other degenerative diseases.
    Type: Grant
    Filed: January 5, 2016
    Date of Patent: June 11, 2019
    Assignee: TOSENSE, INC.
    Inventors: Matthew Banet, Marshal Singh Dhillon, Susan Meeks Pede, Lauren Nicole Miller Hayward, Arthur Deptala, Jonas Dean Cochran
  • Patent number: 10307090
    Abstract: A sensor (1) for detection of gas, in particular for detection of CO2. The sensor (1) has a contact face (2) which can be directed towards a measuring site. The sensor (1) includes at least one radiation source (3), a measurement volume (4) for receiving the gas to be measured, and at least a first detector (5) for detection of radiation transmitted from the source (3) to the first detector (5) through the measurement volume (4). The sensor has a path (6) of the radiation between radiation source (3) and first detector (5). The radiation propagates along the path in a non-imaging way.
    Type: Grant
    Filed: July 21, 2014
    Date of Patent: June 4, 2019
    Assignee: SenTec AG
    Inventors: Dominik Rudmann, Peter Matthias Schumacher, Joseph Lang, Simon Caruel, Christoph Ellenberger-Girard, Ross Stanley, Rolf Eckert, Branislav Timotijevic, Maurizio Tormen
  • Patent number: 10299708
    Abstract: The present disclosure relates to noninvasive methods, devices, and systems for measuring various blood constituents or analytes, such as glucose. In an embodiment, a light source comprises LEDs and super-luminescent LEDs. The light source emits light at least wavelengths of about 1610 nm, about 1640 nm, and about 1665 nm. In an embodiment, the detector comprises a plurality of photodetectors arranged in a special geometry comprising one of a substantially linear substantially equal spaced geometry, a substantially linear substantially non-equal spaced geometry, and a substantially grid geometry.
    Type: Grant
    Filed: January 29, 2019
    Date of Patent: May 28, 2019
    Assignee: MASIMO CORPORATION
    Inventors: Jeroen Poeze, Marcelo Lamego, Sean Merritt, Cristiano Dalvi, Hung Vo, Johannes Bruinsma, Ferdyan Lesmana, Massi Joe E. Kiani, Greg Olsen
  • Patent number: 10292663
    Abstract: A method for monitoring autoregulation includes receiving a blood pressure signal and an oxygen saturation signal, determining a phase difference between the blood pressure signal and the oxygen saturation signal, and determining a patient's autoregulation status based at least in part on a phase difference between the blood pressure signal and the oxygen saturation signal.
    Type: Grant
    Filed: June 27, 2016
    Date of Patent: May 21, 2019
    Assignee: Covidien LP
    Inventors: Paul S. Addison, James N. Watson
  • Patent number: 10292628
    Abstract: The present disclosure relates to noninvasive methods, devices, and systems for measuring various blood constituents or analytes, such as glucose. In an embodiment, a light source comprises LEDs and super-luminescent LEDs. The light source emits light at least wavelengths of about 1610 nm, about 1640 nm, and about 1665 nm. In an embodiment, the detector comprises a plurality of photodetectors arranged in a special geometry comprising one of a substantially linear substantially equal spaced geometry, a substantially linear substantially non-equal spaced geometry, and a substantially grid geometry.
    Type: Grant
    Filed: January 29, 2019
    Date of Patent: May 21, 2019
    Assignee: MASIMO CORPORATION
    Inventors: Jeroen Poeze, Marcelo Lamego, Sean Merritt, Cristiano Dalvi, Hung Vo, Johannes Bruinsma, Ferdyan Lesmana, Massi Joe E. Kiani, Greg Olsen
  • Patent number: 10285631
    Abstract: A band limiter comprises an optical filter, which has first and second filter sections, and a filter moving mechanism for moving the optical filter to place the first or second filter section in a light path of blue light. A passband where transmittance of the first filter section is greater than or equal to half a peak value thereof is defined as a first transmission band. The first transmission band includes a peak wavelength, at which an absorption coefficient of hemoglobin is at its peak. A passband where transmittance of the second filter section is greater than or equal to half a peak value thereof is defined as a second transmission band. The second transmission band does not include an isosbestic wavelength (in the order of 450 nm), at which an absorption coefficient of oxyhemoglobin equals or crosses an absorption coefficient of deoxyhemoglobin.
    Type: Grant
    Filed: August 28, 2015
    Date of Patent: May 14, 2019
    Assignee: FUJIFILM Corporation
    Inventors: Yoshinori Morimoto, Satoshi Ozawa
  • Patent number: 10278628
    Abstract: A band limiter comprises an optical filter, which has first and second filter sections, and a filter moving mechanism for moving the optical filter. The first filter section reduces intensity of blue light, which is emitted from a B-LED, in a wavelength range of greater than or equal to a peak wavelength of the blue light to generate first blue light. The second filter section reduces intensity of the blue light in a wavelength range of less than or equal to the peak wavelength of the blue light to generate second blue light. A light source controller places the first filter section in a light path of the blue light in a normal mode to generate the first blue light, and places the second filter section in the light path of the blue light in an oxygen saturation mode to generate the second blue light.
    Type: Grant
    Filed: August 28, 2015
    Date of Patent: May 7, 2019
    Assignee: FUJIFILM Corporation
    Inventors: Yoshinori Morimoto, Satoshi Ozawa
  • Patent number: 10278648
    Abstract: Automated critical congenital heart defect (“CCHD”) screening systems and processes are described. A caregiver may be guided to use a single or dual sensor pulse oximeter to obtain pre- and post-ductal blood oxygenation measurements. A delta of the measurements indicates the possible existence or nonexistence of a CCHD. Errors in the measurements are reduced by a configurable measurement confidence threshold based on, for example, a perfusion index. Measurement data may be stored and retrieved from a remote data processing center for repeated screenings.
    Type: Grant
    Filed: September 28, 2016
    Date of Patent: May 7, 2019
    Assignee: MASIMO CORPORATION
    Inventors: Ammar Al-Ali, Bilal Muhsin
  • Patent number: 10271745
    Abstract: Examples of monolithic integrated emitter-detector array in a flexible substrate for biometric sensing and associated devices and methods are disclosed. One disclosed example device includes a flexible substrate; a first array of emitters embedded in the flexible substrate, the first array of emitters configured to emit first electromagnetic (EM) signals; a first array of detectors embedded in the flexible substrate, the first array of detectors configured to detect reflections of the first EM signals; a first scanning circuit coupled to the first array of emitters, the first scanning circuit configured to selectively activate individual emitters of the first array of emitters; and a first sensing circuit coupled to individual detectors of the first array of detectors, the first sensing circuit configured to receive a detection signal from at least one of the detectors of the first array of detectors.
    Type: Grant
    Filed: June 17, 2016
    Date of Patent: April 30, 2019
    Assignee: QUALCOMM Incorporated
    Inventors: Shiqun Gu, Matthew Michael Nowak, Kenneth Kaskoun, Eugene Dantsker, Russel Allyn Martin
  • Patent number: 10271779
    Abstract: A method for monitoring autoregulation includes using a processor for receiving blood pressure data and oxygen saturation data from a patient, fitting a dynamic model to the blood pressure data and the oxygen saturation data to determine one or more parameters of the dynamic model indicative of autoregulation, and determining the patient's autoregulation status based on the one or more parameters.
    Type: Grant
    Filed: June 27, 2016
    Date of Patent: April 30, 2019
    Assignee: Covidien LP
    Inventors: Paul S. Addison, James N. Watson
  • Patent number: 10258265
    Abstract: The present disclosure relates to noninvasive methods, devices, and systems for measuring various blood constituents or analytes, such as glucose. In an embodiment, a light source comprises LEDs and super-luminescent LEDs. The light source emits light at least wavelengths of about 1610 nm, about 1640 nm, and about 1665 nm. In an embodiment, the detector comprises a plurality of photodetectors arranged in a special geometry comprising one of a substantially linear substantially equal spaced geometry, a substantially linear substantially non-equal spaced geometry, and a substantially grid geometry.
    Type: Grant
    Filed: December 6, 2018
    Date of Patent: April 16, 2019
    Assignee: MASIMO CORPORATION
    Inventors: Jeroen Poeze, Marcelo Lamego, Sean Merritt, Cristiano Dalvi, Hung Vo, Johannes Bruinsma, Ferdyan Lesmana, Massi Joe E. Kiani, Greg Olsen
  • Patent number: 10258266
    Abstract: The present disclosure relates to noninvasive methods, devices, and systems for measuring various blood constituents or analytes, such as glucose. In an embodiment, a light source comprises LEDs and super-luminescent LEDs. The light source emits light at least wavelengths of about 1610 nm, about 1640 nm, and about 1665 nm. In an embodiment, the detector comprises a plurality of photodetectors arranged in a special geometry comprising one of a substantially linear substantially equal spaced geometry, a substantially linear substantially non-equal spaced geometry, and a substantially grid geometry.
    Type: Grant
    Filed: December 6, 2018
    Date of Patent: April 16, 2019
    Assignee: MASIMO CORPORATION
    Inventors: Jeroen Poeze, Marcelo Lamego, Sean Merritt, Cristiano Dalvi, Hung Vo, Johannes Bruinsma, Ferdyan Lesmana, Massi Joe E. Kiani, Greg Olsen
  • Patent number: 10201299
    Abstract: The present invention relates to a chemo-optical sensor unit for transcutaneous measurement of a concentration of a gas, comprising: at least one gas-permeable sensing layer adapted to be irradiated with a predetermined radiation; and at least a first gas-permeable layer adjacent to one side of the at least one sensing layer, adapted to pass gas whose concentration is to be measured through the gas-permeable layer towards the sensing layer; at least one volatile acid and/or base binding layer in the gas-pathway from the skin to the sensing layer; adapted to pass gas whose concentration is to be measured through the volatile acid and/or base binding layer towards the sensing layer; wherein said chemo-optical sensor unit is adapted to operate with a contact medium between the chemo-optical sensor unit and the skin and wherein the chemo-optical sensor unit is adapted to measure an optical response of the at least one sensing layer, whose optical response depends on the concentration of the gas.
    Type: Grant
    Filed: December 23, 2014
    Date of Patent: February 12, 2019
    Assignee: KONINKLIJKE PHILIPS N.V.
    Inventors: Josephus Arnoldus Henricus Maria Kahlman, Nicolaas Lambert, Hans Willem Van Kesteren
  • Patent number: 9392945
    Abstract: Automated critical congenital heart defect (“CCHD”) screening systems and processes are described. A caregiver may be guided to use a single or dual sensor pulse oximeter to obtain pre- and post-ductal blood oxygenation measurements. A delta of the measurements indicates the possible existence or nonexistence of a CCHD. Errors in the measurements are reduced by a configurable measurement confidence threshold based on, for example, a perfusion index. Measurement data may be stored and retrieved from a remote data processing center for repeated screenings.
    Type: Grant
    Filed: January 3, 2013
    Date of Patent: July 19, 2016
    Assignee: Masimo Corporation
    Inventors: Ammar Al-Ali, Bilal Muhsin